Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The Record History page now lists a 'Study Status' change and shows an updated latest entry dated 2025-12-01 (version 40).
    Difference
    0.3%
    Check dated 2025-12-01T22:51:12.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history.
    Difference
    0.1%
    Check dated 2025-11-24T21:17:02.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The government funding notice banner was removed from the page. No trial data or record details were changed.
    Difference
    0.5%
    Check dated 2025-11-17T18:36:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The new version updates the study status. It also revises the Contacts/Locations section, altering location entries and contact details.
    Difference
    0.1%
    Check dated 2025-11-03T13:16:29.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    10%
    Check dated 2025-10-06T04:15:56.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page’s versioning/metadata was updated to v3.1.0 with a new date and study status entry, while an older date and version (v3.0.2) were removed. Overall, core content remains unchanged.
    Difference
    1%
    Check dated 2025-09-28T23:37:46.000Z thumbnail image

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.